Melissa Vanray
Optometrist · Westminster, CONPI 1104017409
Payments from drug & device makers
Across 47 payments — averaging $19.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson Vision Care, Inc.$217
- Alcon$147
- Oyster Point Pharma, Inc.$131
- Bausch & Lomb Americas Inc.$129
- Bausch & Lomb, A Division Of Bausch Health US, LLC$105
- Sun Pharmaceutical Industries Inc.$43
- plus $153 from 6 others
What the payments were for
- Food & beverage$924100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson Vision Care, Inc. | 11 | $217 |
| Alcon | 10 | $147 |
| Oyster Point Pharma, Inc. | 6 | $131 |
| Bausch & Lomb Americas Inc. | 6 | $129 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 5 | $105 |
| Sun Pharmaceutical Industries Inc. | 2 | $43 |
| Novartis | 2 | $38 |
| Dompe US, Inc. | 1 | $31 |
| Tarsus Pharmaceuticals, Inc. | 1 | $29 |
| Shire North American Group Inc | 1 | $21 |
| Kala Pharmaceuticals, Inc. | 1 | $20 |
| Lombart Brothers, Inc. | 1 | $14 |
How this compares
$924 in reported general payments places this provider in the 60th percentile of 1,025 optometrist providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| LumiganBimatoprost | 19 | $9,166 |
| CombiganBrimonidine Tartrate/Timolol | 15 | $2,717 |
| Timolol Maleate | 27 | $276 |
| Latanoprost | 30 | $254 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 12 | $122 |
Paid to pharmacies, not to this prescriber.
Other optometrist in Westminster
- Cecelia KoettingAurora$458K
- Blake SimmonsColorado Springs$417K
- Kaleb AbbottAurora$185K
- Joshua OlsonBoulder$80K
- Felicia PopowskiFt Carson$80K
- Lisa HamiltonLittleton$73K
- Kent GodfreyGreenwood Village$49K
- Jason OrtmanCastle Pines$45K
- Scott GundersonBroomfield$43K
- Scot MorrisConifer$33K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.